ctrl K

Watchlist Price Alert

Viracta Therapeutics Inc. (VIRX)

OTC: VIRX · Real-Time Price · USD

0.02

-0.00 (-6.54%)

At close: Apr 04, 2025, 3:28 PM

Viracta Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	120K	2.07M	237K	669K	2.54M
Cost of Revenue	492K	210K	178K	32K	n/a	-902.75K	9K	n/a
Gross Profit	-492K	-210K	-178K	88K	2.07M	1.14M	660K	2.54M
Operating Income	-50.69M	-50.59M	62.5M	-18.82M	-23.29M	-25.71M	-34.42M	-36.46M
Interest Income	3.35M	1.17M	38K	48K	472K	n/a	n/a	n/a
Pretax Income	-51.06M	-49.2M	-114.76M	-19.02M	-23.33M	-26.61M	-35.46M	-38.02M
Net Income	-51.06M	-49.77M	-203.06M	-19.2M	-23.33M	-26.61M	-35.46M	-38.02M
Selling & General & Admin	17.32M	24.33M	15.44M	5.35M	9.95M	11.32M	13.54M	16.1M
Research & Development	33.37M	26.26M	23.86M	13.47M	15.41M	14.62M	21.54M	22.88M
Other Expenses	n/a	1.39M	-13.5M	-34K	n/a	n/a	n/a	n/a
Operating Expenses	50.69M	50.59M	25.8M	18.82M	25.36M	25.94M	35.08M	38.98M
Interest Expense	3.7M	577K	491K	216K	514K	1.15M	1.4M	1.72M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	9.95M	9.18M	-9K	-11K
Cost & Expenses	50.69M	50.59M	25.8M	18.82M	25.36M	25.95M	35.09M	39M
Income Tax Expense	n/a	577K	88.3M	182K	514K	1.15M	1.4M	1.72M
Shares Outstanding (Basic)	38.62M	37.79M	31.87M	92.78K	2.49M	1.02M	700.46K	448.23K
Shares Outstanding (Diluted)	38.62M	37.79M	31.87M	92.78K	2.49M	1.02M	700.46K	448.23K
EPS (Basic)	-1.32	-1.32	-6.37	-206.93	-9.37	-26.18	-50.62	-84.83
EPS (Diluted)	-1.32	-1.32	-6.37	-206.93	-9.37	-26.18	-50.62	-84.83
EBITDA	-46.86M	-48.41M	-114.09M	-18.77M	-22.82M	-25.45M	-34.05M	-36.29M
EBIT	-47.35M	-48.62M	-114.27M	-18.8M	-22.82M	-25.46M	-34.06M	-36.3M
Depreciation & Amortization	492K	210K	178K	32K	3.13K	9K	9K	11K